Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q2 2022 (← Previous) (Next →)

Filing Date: Aug 3, 2022

Total Value ($000): $240,803 (100.0% shares, 0.0% debt)

Holdings (6)

CNTA CENTESSA PHARMACEUTICALS PLC 40.4%

Value ($000) $97,221 Shares 19,963,157 Est. Cost $20.88 Unrealized —

AURA AURA BIOSCIENCES INC 17.9%

Value ($000) $43,075 Shares 3,039,892 Est. Cost $17.87 Unrealized -7.4%

PCVX VAXCYTE INC 17.1%

Value ($000) $41,071 Shares 1,887,478 Est. Cost $32.16 Unrealized -28.0%

— MERUS N V 15.0%

Value ($000) $36,224 Shares 1,600,000 Est. Cost $14.08 Unrealized —

PHAT PHATHOM PHARMACEUTICALS INC 8.6%

Value ($000) $20,684 Shares 2,450,679 Est. Cost $22.81 Unrealized -54.9%

— OBSEVA SA 1.0%

Value ($000) $2,528 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$97,221	40.4%	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$43,075	17.9%	$17.87	-7.4%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$41,071	17.1%	$32.16	-28.0%	COM	92243G108
—	MERUS N V	1,600,000	$36,224	15.0%	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,450,679	$20,684	8.6%	$22.81	-54.9%	COM	71722W107
—	OBSEVA SA	1,570,000	$2,528	1.0%	$3.82	—	COM	H5861P103